Ventricular Dysfunction and Dilation in Severe Sepsis and Septic Shock: Relation to Endothelial Function and Mortality
Overview
Authors
Affiliations
Purpose: The aim of this study was to evaluate echocardiography-based indices of myocardial function and markers of vascular inflammation and endothelial dysfunction in the early phases of severe sepsis.
Material And Methods: Forty-five adult patients (67% women; age 51 ± 18 years; Acute Physiology and Chronic Health Disease Classification System II score, 23 ± 7) admitted to the intensive care unit up to 24 hours after fulfilling criteria for severe sepsis or septic shock were studied. Clinical, laboratorial (endothelin 1 [ET1], vascular cellular adhesion molecule 1), and echocardiographic data were collected within the first 24 hours and again 72 hours and 7 days after admission.
Results: Intrahospital mortality was 33% (15 deaths). Left ventricular (LV) dysfunction (LV ejection fraction <55%) was identified in 15 (33%) patients, whereas right ventricular (RV) dysfunction (RV tissue Doppler peak systolic velocity [RV-Sm] <12 cm/s) was present in 14 (30%) patients. LogET1 was increased in patients with LV dysfunction (2.3 ± 0.6 vs 1.8 ± 0.4 pg/mL; P = .01) and RV dysfunction (2.5 ± 0.5 vs 1.8 ± 0.4 pg/mL; P < .001) and had negative correlations with LV ejection fraction (r = -0.50; P = .002) and RV-Sm (r = -0.67; P < .001). Left ventricular end-diastolic diameter, RV-Sm, and diastolic dysfunction were able to discriminate survivors from nonsurvivors, and the combination of these parameters identified groups of very low and high risk.
Conclusion: Both LV and RV systolic dysfunctions are prevalent in severe sepsis, being directly associated with markers of endothelial dysfunction. Left ventricular nondilation, RV dysfunction, and diastolic dysfunction seem related to poor prognosis in this scenario.
Septic Cardiomyopathy: Difficult Definition, Challenging Diagnosis, Unclear Treatment.
Zakynthinos G, Giamouzis G, Xanthopoulos A, Oikonomou E, Kalogeras K, Karavidas N J Clin Med. 2025; 14(3).
PMID: 39941657 PMC: 11818464. DOI: 10.3390/jcm14030986.
Revealing Landscape of Competing Endogenous RNA Networks in Sepsis-Induced Cardiovascular Diseases.
Xiong W, Feng S, Zhao Y, Liu X, Gong J Rev Cardiovasc Med. 2024; 24(7):214.
PMID: 39077015 PMC: 11266464. DOI: 10.31083/j.rcm2407214.
Ford V, Applefeld W, Wang J, Sun J, Solomon S, Sidenko S bioRxiv. 2024; .
PMID: 38903100 PMC: 11188083. DOI: 10.1101/2024.02.05.578971.
Types of Septic Cardiomyopathy: Prognosis and Influencing Factors - A Clinical Study.
Lu N, Niu H, Liu A, Chen Y, Liu H, Zhao P Risk Manag Healthc Policy. 2024; 17:1015-1025.
PMID: 38680475 PMC: 11055516. DOI: 10.2147/RMHP.S452803.
Clinical implications of septic cardiomyopathy: A narrative review.
Hiraiwa H, Kasugai D, Okumura T, Murohara T Medicine (Baltimore). 2024; 103(17):e37940.
PMID: 38669408 PMC: 11049701. DOI: 10.1097/MD.0000000000037940.